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Bone surgery as a current bone treatment method is not always successful to fulfil 
bone repair in bone degenerative diseases or extensive injuries. Due to the limited 
capacity of bone remodeling, the demand for alternative approaches remains to 
be met. Thus, efforts in ex vivo generation of bone forming cells, osteoblasts, and 
their further application in cell therapy as a promising approach are of vital 
prominence from a scientific perspective. Though several studies have focused 
on microRNA roles in osteoblast differentiation in various cell recourses, yet 
none has reported miR-210 enhancing role in human mesynchymal stem cells 
(MSCs) so far. Hence, we wished to examine the nature of the relationship 
between osteoblast differentiation and miR-210 in a unique human mesynchymal 
stem cells, unrestricted somatic stem cells (USSCs). Osteoblast markers at gene 
level namely, Runx2, col I in addition to osteocalcin were assessed using qRT-
PCR, and Alizarin red S staining was also carried out to observe histochemical 
changes 7 days following miR-210 transduction. The conclusion that follows 
from our findings represents a marked increase in osteoblast differentiation 
markers. Interestingly, for the first time, human USSCs differentiation into 
osteoblasts was performed in our research. On the whole, our study may provide 
helpful insights into surmounting bone related issues by combination of both gene 
and cell therapy.  
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